Yumanity Therapeutics, Inc.
(NASDAQ) YMTX
Yumanity Therapeutics, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$8.46
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
YMTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Yumanity Therapeutics, Inc.
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Shawn P. Iadonato, PhD
Website
www.kinetabio.comHeadquarters
Boston, MA 02135, US
YMTX Financials
Key Financial Metrics (TTM)
Gross Margin
2%
Operating Margin
-53%
Net Income Margin
-76%
Return on Equity
26%
Return on Capital
17%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$13.53M
EBITDA
$13.53M
Operating Cash Flow
$11.57M
Capital Expenditure
$0.00
Free Cash Flow
$11.57M
Cash & ST Invst.
$634.00K
Total Debt
$629.00K
Yumanity Therapeutics, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
40
N/A
Net Income
$1.68M
N/A
EBITDA
$2.02M
N/A
Quarterly Fundamentals
Net Cash
$325.00K
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$629.00K
N/A
Return on Assets
-3.93%
N/A
Return on Invested Capital
17.33%
N/A
Free Cash Flow
$1.44M
N/A
Operating Cash Flow
$1.44M
N/A